Co-occurrence of Neuromyelitis Optica Spectrum Disorder and Idiopathic Multicentric Castleman Disease Successfully Treated with Tocilizumab: A Case Report

被引:0
|
作者
Wada, Takuma Tsuzuki [1 ]
Yokota, Kazuhiro [1 ]
Okada, Mariko [2 ]
Ichimura, Takaya [3 ]
Ueno, Takehito [1 ]
Okumura, Nobuhito [1 ]
Osawa, Iichiro [4 ]
Inoue, Kaiji [4 ]
Akiyama, Yuji [1 ]
Nakazato, Yoshihiko [2 ]
Sasaki, Atsushi
Yamamoto, Toshimasa [2 ]
Mimura, Toshihide [1 ]
机构
[1] Saitama Med Univ, Fac Med, Dept Rheumatol & Appl Immunol, Irama, Japan
[2] Saitama Med Univ, Fac Med, Dept Neurol, Saitama, Japan
[3] Saitama Med Univ, Fac Med, Dept Pathol, Saitama, Japan
[4] Saitama Med Univ Hosp, Dept Radiol, Saitama, Japan
关键词
neuromyelitis optica spectrum disorder; Castleman disease; interleukin-6; tocilizumab; ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY; DIAGNOSTIC-CRITERIA; EFFICACY; PLASMABLASTS; SATRALIZUMAB; AQUAPORIN-4; SAFETY;
D O I
10.2169/internalmedicine.4503-24
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We herein report a 52-year-old woman with anti-aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder (NMOSD) and idiopathic multicentric Castleman disease (iMCD) who was successfully treated with tocilizumab, a humanized anti-human interleukin (IL)-6 receptor monoclonal antibody. This is the first report of a case of coexisting NMOSD and iMCD. IL-6 is involved in the pathogenesis of both NMOSD and iMCD, and tocilizumab is effective against both diseases. By treating the patient with tocilizumab, the lung lesions due to iMCD improved, and the neurological symptoms of NMOSD did not recur.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report
    Komai, Toshihiko
    Shoda, Hirofumi
    Yamaguchi, Kenichi
    Sakurai, Keiichi
    Shibuya, Mihoko
    Kubo, Kanae
    Takahashi, Toshiyuki
    Fujio, Keishi
    Yamamoto, Kazuhiko
    MODERN RHEUMATOLOGY, 2016, 26 (02) : 294 - 296
  • [2] A case of tocilizumab-refractory idiopathic multicentric Castleman's disease successfully treated with sirolimus
    Sumiyoshi, Remi
    Koga, Tomohiro
    Furukawa, Kaori
    Umeda, Masataka
    Yamamoto, Kazuko
    Mori, Ryoichi
    Kawakami, Atsushi
    CLINICAL IMMUNOLOGY, 2021, 233
  • [3] Idiopathic multicentric Castleman disease preceded by cutaneous plasmacytosis successfully treated by tocilizumab
    Aita, Tetsuro
    Hamaguchi, Sugihiro
    Shimotani, Yoko
    Nakamoto, Yohei
    BMJ CASE REPORTS, 2020, 13 (11)
  • [4] Idiopathic multicentric Castleman disease and connective tissue disorder successfully treated by siltuximab: a pediatric case report
    Hu, Shiwen
    Li, Zifeng
    Zhang, Haiyan
    Li, Yifan
    Yang, Jiajian
    Ma, Yangyang
    Chen, Lian
    Sun, Li
    Zhai, Xiaowen
    TRANSLATIONAL PEDIATRICS, 2024, 13 (05) : 824 - 832
  • [5] Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report
    Ping-Yang Han
    Hui-Hui Chi
    Yu-Tong Su
    World Journal of Clinical Cases, 2020, (20) : 4922 - 4929
  • [6] Idiopathic multicentric Castleman disease with pulmonary and cutaneous lesions treated with tocilizumab: A case report
    Han, Ping-Yang
    Chi, Hui-Hui
    Su, Yu-Tong
    WORLD JOURNAL OF CLINICAL CASES, 2020, 8 (20) : 4922 - 4929
  • [7] Tocilizumab during pregnancy for neuromyelitis optica spectrum disorder: a case report
    Capobianco, M.
    Marozio, L.
    Coscia, A.
    Malentacchi, M.
    Bertolotto, A.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 399 - 399
  • [8] Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature
    Saiki, Ryosuke
    Katayama, Kan
    Hirabayashi, Yosuke
    Oda, Keiko
    Fujimoto, Mika
    Murata, Tomohiro
    Nakajima, Ayako
    Dohi, Kaoru
    BMC NEPHROLOGY, 2021, 22 (01)
  • [9] Neuromyelitis optica spectrum disorder safely and successfully treated with satralizumab during pregnancy and breastfeeding: a case report
    Yoshida, Takashi
    Watanabe, Osamu
    Nomura, Miwa
    Yoshimoto, Yusuke
    Maki, Yoshimitsu
    Takashima, Hiroshi
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [10] Membranous nephropathy associated with multicentric Castleman’s disease that was successfully treated with tocilizumab: a case report and review of the literature
    Ryosuke Saiki
    Kan Katayama
    Yosuke Hirabayashi
    Keiko Oda
    Mika Fujimoto
    Tomohiro Murata
    Ayako Nakajima
    Kaoru Dohi
    BMC Nephrology, 22